Literature DB >> 27403316

Reply to letter to the editor: "The dosage of rifabutin in H. pylori eradication regimen should be appropriately determined in each area of the world".

Hideki Mori1, Hidekazu Suzuki2.   

Abstract

Entities:  

Year:  2016        PMID： 27403316      PMCID： PMC4924443          DOI： 10.1177/2050640616631477

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN： 2050-6406            Impact factor:   4.623


× No keyword cloud information.
  9 in total

1.  Enhancement of amoxicillin resistance after unsuccessful Helicobacter pylori eradication.

Authors:  Toshihiro Nishizawa; Hidekazu Suzuki; Hitoshi Tsugawa; Hiroe Muraoka; Juntaro Matsuzaki; Kenro Hirata; Fumiaki Ikeda; Masahiko Takahashi; Toshifumi Hibi
Journal:  Antimicrob Agents Chemother       Date:  2011-04-12       Impact factor: 5.191

2.  Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection.

Authors:  W M Wong; Q Gu; S K Lam; F M Y Fung; K C Lai; W H C Hu; Y K Yee; C K Chan; H H X Xia; M F Yuen; B C Y Wong
Journal:  Aliment Pharmacol Ther       Date:  2003-02-15       Impact factor: 8.171

3.  Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies.

Authors:  F Perri; V Festa; R Clemente; M R Villani; M Quitadamo; N Caruso; M L Bergoli; A Andriulli
Journal:  Am J Gastroenterol       Date:  2001-01       Impact factor: 10.864

Review 4.  Review article: rifabutin in the treatment of refractory Helicobacter pylori infection.

Authors:  J P Gisbert; X Calvet
Journal:  Aliment Pharmacol Ther       Date:  2011-11-30       Impact factor: 8.171

5.  Ethnic differences between Japanese and Caucasians in the expression levels of mRNAs for CYP3A4, CYP3A5 and CYP3A7: lack of co-regulation of the expression of CYP3A in Japanese livers.

Authors:  S Yamaori; H Yamazaki; S Iwano; K Kiyotani; K Matsumura; T Saito; A Parkinson; K Nakagawa; T Kamataki
Journal:  Xenobiotica       Date:  2005-01       Impact factor: 1.908

6.  Efficacy of 10-day Sitafloxacin-Containing Third-Line Rescue Therapies for Helicobacter pylori Strains Containing the gyrA Mutation.

Authors:  Hideki Mori; Hidekazu Suzuki; Juntaro Matsuzaki; Hitoshi Tsugawa; Seiichiro Fukuhara; Sawako Miyoshi; Kenro Hirata; Takashi Seino; Misako Matsushita; Tatsuhiro Masaoka; Takanori Kanai
Journal:  Helicobacter       Date:  2015-11-27       Impact factor: 5.753

7.  Indinavir and rifabutin drug interactions in healthy volunteers.

Authors:  Walter K Kraft; Jacqueline B McCrea; Gregory A Winchell; Alexandra Carides; Richard Lowry; Eric J Woolf; Sandra E Kusma; Paul J Deutsch; Howard E Greenberg; Scott A Waldman
Journal:  J Clin Pharmacol       Date:  2004-03       Impact factor: 3.126

Review 8.  How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?

Authors:  Enzo Ierardi; Floriana Giorgio; Giuseppe Losurdo; Alfredo Di Leo; Mariabeatrice Principi
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

9.  Efficacy of a "Rescue" Ciprofloxacin-Based Regimen for Eradication of Helicobacter pylori Infection after Treatment Failures.

Authors:  Maria Pina Dore; Vincenza Tadeu; Bianca Are; Ida Mura; Giuseppe Fanciulli; Giovannino Massarelli; Andrea Piana
Journal:  Gastroenterol Res Pract       Date:  2012-05-14       Impact factor: 2.260
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.